Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.96% | 310.42 | 0.0% | $5225.43m | |
| BNTX | BioNTech SE | 3.25% | 344.33 | 0.0% | $1582.56m | |
| NVAX | Novavax, Inc. | -0.92% | 160.48 | 78.2% | $849.64m | |
| AMGN | Amgen, Inc. | 0.49% | 202.16 | 1.4% | $596.16m | |
| GILD | Gilead Sciences, Inc. | -0.22% | 69.52 | 1.0% | $508.69m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.71% | 202.99 | 1.9% | $475.58m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.10% | 627.01 | 2.7% | $468.81m | |
| LGVN | Longeveron Inc. | 17.78% | 21.20 | 0.0% | $422.79m | |
| ILMN | Illumina, Inc. | -3.12% | 346.33 | 3.3% | $315.11m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -2.57% | 4.17 | 0.7% | $291.50m | |
| BIIB | Biogen, Inc. | -2.42% | 223.00 | 1.8% | $272.25m | |
| OCGN | Ocugen, Inc. | -9.05% | 5.74 | 0.0% | $192.62m | |
| INCY | Incyte Corp. | -1.52% | 65.62 | 2.4% | $153.86m | |
| EXAS | EXACT Sciences Corp. | -5.37% | 76.24 | 18.0% | $147.67m | |
| SGEN | Seagen Inc. | -4.92% | 150.87 | 5.8% | $143.95m |
Company Profile
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.